The mainstay of treatment for type 1 diabetes (T1D) is exogenous insulin. Here, we report a case in which exogenous insulin requirements were eliminated after an allogeneic hematopoietic stem cell transplant for aplastic anemia in a pediatric patient recently diagnosed with T1D, and explore the validity of this approach compared with current treatments.
Keywords: aplastic anemia; autoimmune; transplant; type 1 diabetes.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.